Description
An ALK and IGF-1R inhibitor; inhibits ALK (IC50 = 15 nM); inhibits the proliferation of neuroblastoma cells with WT ALK (IC50s = 2.8-21.3 µM) or ALK containing activating mutations (IC50s = 1.7 and 16.49 µM for ALKF1174L and ALKD1091N, respectively); reduces tumor growth in neuroblastoma mouse xenograft models expressing WT ALK or the ALKF1174L mutation at 15 mg/kg per day for 21 days
Formal name: N-[4-(4-amino-1-piperidinyl)-2-methoxyphenyl]-5-chloro-4-(1H-indol-3-yl)-2-pyrimidinamine
Synonyms:
Molecular weight: 449
CAS: 1356962-20-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|IGF-1R/InsR Family||Product Type|Biochemicals|Kinase Inhibitors|Other Receptor Tyrosine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Autophagy||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Cancer|Cell Signaling